Back to top

Can-Fite Hikes on Patent Success

Can-Fite BioPharma Ltd. (NYSE: CANF) moved higher Friday. The Israel-based company, a clinical-stage biotechnology concern developing a pipeline of proprietary small molecule drugs targeting oncological ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Can-Fite Biopharma Ltd (CANF)